Request for Covid-19 Impact Assessment of this Report
The United States Intravenous Human Immunoglobulin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous Human Immunoglobulin market, reaching US$ million by the year 2028. As for the Europe Intravenous Human Immunoglobulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Intravenous Human Immunoglobulin players cover Baxter, Grifols, CSL, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Human Immunoglobulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Liquid
Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Specialty Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Tiantan Biological(Sinopharm)
Taibang Biologic Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Human Immunoglobulin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous Human Immunoglobulin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous Human Immunoglobulin by Country/Region, 2017, 2022 & 2028
2.2 Intravenous Human Immunoglobulin Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.3 Intravenous Human Immunoglobulin Sales by Type
2.3.1 Global Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous Human Immunoglobulin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous Human Immunoglobulin Sale Price by Type (2017-2022)
2.4 Intravenous Human Immunoglobulin Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 Intravenous Human Immunoglobulin Sales by Application
2.5.1 Global Intravenous Human Immunoglobulin Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous Human Immunoglobulin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous Human Immunoglobulin Sale Price by Application (2017-2022)
3 Global Intravenous Human Immunoglobulin by Company
3.1 Global Intravenous Human Immunoglobulin Breakdown Data by Company
3.1.1 Global Intravenous Human Immunoglobulin Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous Human Immunoglobulin Sales Market Share by Company (2020-2022)
3.2 Global Intravenous Human Immunoglobulin Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous Human Immunoglobulin Revenue by Company (2020-2022)
3.2.2 Global Intravenous Human Immunoglobulin Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous Human Immunoglobulin Sale Price by Company
3.4 Key Manufacturers Intravenous Human Immunoglobulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Human Immunoglobulin Product Location Distribution
3.4.2 Players Intravenous Human Immunoglobulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravenous Human Immunoglobulin by Geographic Region
4.1 World Historic Intravenous Human Immunoglobulin Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous Human Immunoglobulin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous Human Immunoglobulin Annual Revenue by Geographic Region
4.2 World Historic Intravenous Human Immunoglobulin Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous Human Immunoglobulin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous Human Immunoglobulin Annual Revenue by Country/Region
4.3 Americas Intravenous Human Immunoglobulin Sales Growth
4.4 APAC Intravenous Human Immunoglobulin Sales Growth
4.5 Europe Intravenous Human Immunoglobulin Sales Growth
4.6 Middle East & Africa Intravenous Human Immunoglobulin Sales Growth
5 Americas
5.1 Americas Intravenous Human Immunoglobulin Sales by Country
5.1.1 Americas Intravenous Human Immunoglobulin Sales by Country (2017-2022)
5.1.2 Americas Intravenous Human Immunoglobulin Revenue by Country (2017-2022)
5.2 Americas Intravenous Human Immunoglobulin Sales by Type
5.3 Americas Intravenous Human Immunoglobulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Human Immunoglobulin Sales by Region
6.1.1 APAC Intravenous Human Immunoglobulin Sales by Region (2017-2022)
6.1.2 APAC Intravenous Human Immunoglobulin Revenue by Region (2017-2022)
6.2 APAC Intravenous Human Immunoglobulin Sales by Type
6.3 APAC Intravenous Human Immunoglobulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous Human Immunoglobulin by Country
7.1.1 Europe Intravenous Human Immunoglobulin Sales by Country (2017-2022)
7.1.2 Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2022)
7.2 Europe Intravenous Human Immunoglobulin Sales by Type
7.3 Europe Intravenous Human Immunoglobulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Human Immunoglobulin by Country
8.1.1 Middle East & Africa Intravenous Human Immunoglobulin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous Human Immunoglobulin Sales by Type
8.3 Middle East & Africa Intravenous Human Immunoglobulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Human Immunoglobulin
10.3 Manufacturing Process Analysis of Intravenous Human Immunoglobulin
10.4 Industry Chain Structure of Intravenous Human Immunoglobulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Human Immunoglobulin Distributors
11.3 Intravenous Human Immunoglobulin Customer
12 World Forecast Review for Intravenous Human Immunoglobulin by Geographic Region
12.1 Global Intravenous Human Immunoglobulin Market Size Forecast by Region
12.1.1 Global Intravenous Human Immunoglobulin Forecast by Region (2023-2028)
12.1.2 Global Intravenous Human Immunoglobulin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Human Immunoglobulin Forecast by Type
12.7 Global Intravenous Human Immunoglobulin Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Intravenous Human Immunoglobulin Product Offered
13.1.3 Baxter Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Intravenous Human Immunoglobulin Product Offered
13.2.3 Grifols Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Intravenous Human Immunoglobulin Product Offered
13.3.3 CSL Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Intravenous Human Immunoglobulin Product Offered
13.4.3 Octapharma Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Intravenous Human Immunoglobulin Product Offered
13.5.3 Biotest Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Intravenous Human Immunoglobulin Product Offered
13.6.3 Kedrion Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Intravenous Human Immunoglobulin Product Offered
13.7.3 Hualan Bio Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Intravenous Human Immunoglobulin Product Offered
13.8.3 CNBG Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Intravenous Human Immunoglobulin Product Offered
13.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Intravenous Human Immunoglobulin Product Offered
13.10.3 CBPO Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Intravenous Human Immunoglobulin Product Offered
13.11.3 LFB Group Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Intravenous Human Immunoglobulin Product Offered
13.12.3 BPL Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Tiantan Biological(Sinopharm)
13.13.1 Tiantan Biological(Sinopharm) Company Information
13.13.2 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Offered
13.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Tiantan Biological(Sinopharm) Main Business Overview
13.13.5 Tiantan Biological(Sinopharm) Latest Developments
13.14 Taibang Biologic Group
13.14.1 Taibang Biologic Group Company Information
13.14.2 Taibang Biologic Group Intravenous Human Immunoglobulin Product Offered
13.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Taibang Biologic Group Main Business Overview
13.14.5 Taibang Biologic Group Latest Developments
14 Research Findings and Conclusion
Table 1. Intravenous Human Immunoglobulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous Human Immunoglobulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 6. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)
Table 7. Global Intravenous Human Immunoglobulin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2017-2022)
Table 9. Global Intravenous Human Immunoglobulin Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 11. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)
Table 12. Global Intravenous Human Immunoglobulin Revenue by Application (2017-2022)
Table 13. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2017-2022)
Table 14. Global Intravenous Human Immunoglobulin Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Intravenous Human Immunoglobulin Sales by Company (2020-2022) & (K Units)
Table 16. Global Intravenous Human Immunoglobulin Sales Market Share by Company (2020-2022)
Table 17. Global Intravenous Human Immunoglobulin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Intravenous Human Immunoglobulin Revenue Market Share by Company (2020-2022)
Table 19. Global Intravenous Human Immunoglobulin Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Intravenous Human Immunoglobulin Producing Area Distribution and Sales Area
Table 21. Players Intravenous Human Immunoglobulin Products Offered
Table 22. Intravenous Human Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Intravenous Human Immunoglobulin Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Intravenous Human Immunoglobulin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Intravenous Human Immunoglobulin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Intravenous Human Immunoglobulin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Intravenous Human Immunoglobulin Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Intravenous Human Immunoglobulin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Intravenous Human Immunoglobulin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Intravenous Human Immunoglobulin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 34. Americas Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 35. Americas Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 37. Americas Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 38. Americas Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)
Table 39. Americas Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 40. Americas Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)
Table 41. APAC Intravenous Human Immunoglobulin Sales by Region (2017-2022) & (K Units)
Table 42. APAC Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2022)
Table 43. APAC Intravenous Human Immunoglobulin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Intravenous Human Immunoglobulin Revenue Market Share by Region (2017-2022)
Table 45. APAC Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 46. APAC Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)
Table 47. APAC Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 48. APAC Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)
Table 49. Europe Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 50. Europe Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 51. Europe Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 53. Europe Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 54. Europe Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)
Table 55. Europe Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 56. Europe Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Intravenous Human Immunoglobulin Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Intravenous Human Immunoglobulin Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Intravenous Human Immunoglobulin Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Intravenous Human Immunoglobulin
Table 66. Key Market Challenges & Risks of Intravenous Human Immunoglobulin
Table 67. Key Industry Trends of Intravenous Human Immunoglobulin
Table 68. Intravenous Human Immunoglobulin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Intravenous Human Immunoglobulin Distributors List
Table 71. Intravenous Human Immunoglobulin Customer List
Table 72. Global Intravenous Human Immunoglobulin Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Intravenous Human Immunoglobulin Sales Market Forecast by Region
Table 74. Global Intravenous Human Immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Intravenous Human Immunoglobulin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Intravenous Human Immunoglobulin Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Intravenous Human Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Intravenous Human Immunoglobulin Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Intravenous Human Immunoglobulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Intravenous Human Immunoglobulin Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Intravenous Human Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Intravenous Human Immunoglobulin Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Intravenous Human Immunoglobulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Intravenous Human Immunoglobulin Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Intravenous Human Immunoglobulin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Intravenous Human Immunoglobulin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Intravenous Human Immunoglobulin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Intravenous Human Immunoglobulin Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Intravenous Human Immunoglobulin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Intravenous Human Immunoglobulin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Intravenous Human Immunoglobulin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Baxter Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Intravenous Human Immunoglobulin Product Offered
Table 94. Baxter Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Baxter Main Business
Table 96. Baxter Latest Developments
Table 97. Grifols Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Intravenous Human Immunoglobulin Product Offered
Table 99. Grifols Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. CSL Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Intravenous Human Immunoglobulin Product Offered
Table 104. CSL Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Octapharma Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 108. Octapharma Intravenous Human Immunoglobulin Product Offered
Table 109. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Octapharma Main Business
Table 111. Octapharma Latest Developments
Table 112. Biotest Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 113. Biotest Intravenous Human Immunoglobulin Product Offered
Table 114. Biotest Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Biotest Main Business
Table 116. Biotest Latest Developments
Table 117. Kedrion Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 118. Kedrion Intravenous Human Immunoglobulin Product Offered
Table 119. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Kedrion Main Business
Table 121. Kedrion Latest Developments
Table 122. Hualan Bio Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 123. Hualan Bio Intravenous Human Immunoglobulin Product Offered
Table 124. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Hualan Bio Main Business
Table 126. Hualan Bio Latest Developments
Table 127. CNBG Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 128. CNBG Intravenous Human Immunoglobulin Product Offered
Table 129. CNBG Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. CNBG Main Business
Table 131. CNBG Latest Developments
Table 132. Shanghai RAAS Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai RAAS Intravenous Human Immunoglobulin Product Offered
Table 134. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Shanghai RAAS Main Business
Table 136. Shanghai RAAS Latest Developments
Table 137. CBPO Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 138. CBPO Intravenous Human Immunoglobulin Product Offered
Table 139. CBPO Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. CBPO Main Business
Table 141. CBPO Latest Developments
Table 142. LFB Group Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 143. LFB Group Intravenous Human Immunoglobulin Product Offered
Table 144. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. LFB Group Main Business
Table 146. LFB Group Latest Developments
Table 147. BPL Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 148. BPL Intravenous Human Immunoglobulin Product Offered
Table 149. BPL Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. BPL Main Business
Table 151. BPL Latest Developments
Table 152. Tiantan Biological(Sinopharm) Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 153. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Offered
Table 154. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Tiantan Biological(Sinopharm) Main Business
Table 156. Tiantan Biological(Sinopharm) Latest Developments
Table 157. Taibang Biologic Group Basic Information, Intravenous Human Immunoglobulin Manufacturing Base, Sales Area and Its Competitors
Table 158. Taibang Biologic Group Intravenous Human Immunoglobulin Product Offered
Table 159. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Taibang Biologic Group Main Business
Table 161. Taibang Biologic Group Latest Developments
List of Figures
Figure 1. Picture of Intravenous Human Immunoglobulin
Figure 2. Intravenous Human Immunoglobulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Human Immunoglobulin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intravenous Human Immunoglobulin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous Human Immunoglobulin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liquid
Figure 10. Product Picture of Powder
Figure 11. Global Intravenous Human Immunoglobulin Sales Market Share by Type in 2021
Figure 12. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2017-2022)
Figure 13. Intravenous Human Immunoglobulin Consumed in Hospital
Figure 14. Global Intravenous Human Immunoglobulin Market: Hospital (2017-2022) & (K Units)
Figure 15. Intravenous Human Immunoglobulin Consumed in Specialty Clinic
Figure 16. Global Intravenous Human Immunoglobulin Market: Specialty Clinic (2017-2022) & (K Units)
Figure 17. Intravenous Human Immunoglobulin Consumed in Others
Figure 18. Global Intravenous Human Immunoglobulin Market: Others (2017-2022) & (K Units)
Figure 19. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2017-2022)
Figure 20. Global Intravenous Human Immunoglobulin Revenue Market Share by Application in 2021
Figure 21. Intravenous Human Immunoglobulin Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Intravenous Human Immunoglobulin Revenue Market Share by Company in 2021
Figure 23. Global Intravenous Human Immunoglobulin Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Intravenous Human Immunoglobulin Revenue Market Share by Geographic Region in 2021
Figure 25. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2017-2022)
Figure 26. Global Intravenous Human Immunoglobulin Revenue Market Share by Country/Region in 2021
Figure 27. Americas Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)
Figure 28. Americas Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 29. APAC Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)
Figure 30. APAC Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 31. Europe Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)
Figure 32. Europe Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Intravenous Human Immunoglobulin Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Intravenous Human Immunoglobulin Revenue 2017-2022 ($ Millions)
Figure 35. Americas Intravenous Human Immunoglobulin Sales Market Share by Country in 2021
Figure 36. Americas Intravenous Human Immunoglobulin Revenue Market Share by Country in 2021
Figure 37. United States Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Intravenous Human Immunoglobulin Sales Market Share by Region in 2021
Figure 42. APAC Intravenous Human Immunoglobulin Revenue Market Share by Regions in 2021
Figure 43. China Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Intravenous Human Immunoglobulin Sales Market Share by Country in 2021
Figure 50. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country in 2021
Figure 51. Germany Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Country in 2021
Figure 58. Egypt Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Intravenous Human Immunoglobulin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Intravenous Human Immunoglobulin in 2021
Figure 64. Manufacturing Process Analysis of Intravenous Human Immunoglobulin
Figure 65. Industry Chain Structure of Intravenous Human Immunoglobulin
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...